Encision Inc. Applauds the FDA's Safety Communication On The Dangers Of Monopolar Electrosurgery
Encision's AEM® Technology Is The Solution That Eliminates The Dangers BOULDER, Colo., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Encision Inc. (OTC:ECIA), a medical device company owning patented surgical technology that prevents da... Devices, Surgery, FDA Encision, electrosurgery, AEM Technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
VANCOUVER, May 31, 2018 -- (Healthcare Sales & Marketing Network) - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed an Option Agreement wit... Devices, Drug Delivery, Licensing Pivot Pharmaceuticals, IP Med, Trivair Delivery System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
A New Evolution of the Best Selling ESD Knife Provides Lifting and Dissection in One Device CENTER VALLEY, Pa., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutio... Devices, Gastroenterology, Product Launch Olympus Medical Systems, DualKnife J, endoscopic submucosal dissection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Rani Therapeutics Appoints Dr. Rodolphe Ruffy as the Company's First Medical Director
SAN JOSE, Calif., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Rani Therapeutics, a pioneer in oral biologics, today announced that Rodolphe Ruffy, M.D. has joined the company as medical director. Dr. Ruffy brings decades of experience as a p... Biopharmaceuticals, Drug Delivery, Personnel Rani Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Legend Announces FDA Clearance of IND Application on CAR-T Immuno-cell Therapy for the Treatment of Multiple Myeloma
LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen PISCATAWAY, N.J., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Legend Biotech, a subsidiary of GenScript Biotech Corporation... Biopharmaceuticals, Oncology, FDA Legend Biotech, GenScript Biotech, Janssen, CAR-T therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One MADISON, Wis., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital ... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory action underscores the treatment poten... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

FDA Broadens ClearGuard(R) HD Antimicrobial Barrier Cap Indications
ClearGuard HD Caps Have Been Shown to Reduce Central Line-Associated Bloodstream Infections in Hemodialysis Patients MAPLE GROVE, Minn., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Pursuit Vascular, Inc., manufacturer of ClearGuard HD Ant... Devices, FDA Pursuit Vascular, ClearGuard, Antimicrobial Barrier, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Circulating Tumor Cells To Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting
Study adds to significant body of evidence supporting clinical utility of CELLSEARCH BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Menarini Silicon Biosystems announced today that a new study has f... Diagnostics, Oncology Menarini Silicon Biosystems, circulating tumor cells, liquid biopsy, CELLSEARCH (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Phase II clinical trials in patients undergoing hemodialysis to be initiated in Q4, 2018 NEWARK, Delaware, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- TrioxBio Inc., a clinical-stage biopharmaceutical company specializing in the developme... Biopharmaceuticals, FDA TrioxBio, Raviten, ethylisothiouronium, Intradialytic Hypotension, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Zeto EEG provides a better, more convenient experience to patients and technicians and faster turnaround time to hospitals than current technology SANTA CLARA, Calif., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Zeto, Inc., a privately he... Devices, Monitoring, Neurology, FDA Zeto, electroencephalography, EEG headset (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
The U.S. Food and Drug Administration's (FDA) approval of CIMZIA® (certolizumab pegol) for use in moderate-to-severe plaque psoriasis marks the entry of UCB into immuno-dermatology CIMZIA Phase 3 psoriasis studies demonstrated significant and clinic... Biopharmaceuticals, Dermatology, FDA UCB , CIMZIA, certolizumab pegol, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA Grants Priority Review to Astellas' New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
TOKYO, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D. "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has accepted, with Priority R... Biopharmaceuticals, Oncology, FDA Astellas Pharma, gilteritinib, Acute Myeloid Leukemia, FLT3 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

ADAPT Pharma(R) Launches NARCANDirect.com
New online platform for Group Purchasers of NARCAN® (naloxone HCl) Nasal Spray DUBLIN, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- ADAPT Pharma® (Adapt) announced the launch of NARCANDirect.com, an easy-to-use online platform for ... Biopharmaceuticals, Product Launch ADAPT Pharma, NARCANDirect.com, NARCAN , naloxone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
WAYNE, Pa., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for ... Biopharmaceuticals, Reimbursement Egalet Corp, SPRIX , ketorolac tromethamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer
SINGAPORE, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Lion TCR Pte Ltd, a clinical stage biotech pioneering T cell therapy against viral- related cancer, announced today they have raised US$ 20 million in its Series A financing round. The m... Biopharmaceuticals, Oncology, Venture Capital Lion TCR, LioCyx, T-cell, Hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 28, 2018 Category: Pharmaceuticals Source Type: news

Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
A Move Aimed at Enriching the Existing CNS Portfolio and Enhancing Strategic Synergy across International Markets HONG KONG, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Luye Pharma Group recently announced their acquisition of AstraZeneca... Biopharmaceuticals, Neurology, Acquisitions Luye Pharma, AstraZeneca, Seroquel, quetiapine, antipsychotic, antidepressant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 28, 2018 Category: Pharmaceuticals Source Type: news

Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
SLOUGH, England and RICHMOND, Va., May 25, 2018 -- (Healthcare Sales & Marketing Network) -- Indivior PLC (LON: INDV) today announced that it has filed a regulatory submission with Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE™ (bupreno... Biopharmaceuticals, Drug Delivery, Regulatory Indivior, SUBLOCADE, buprenorphine, opioid use disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
VANCOUVER, May 25, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, t... Devices, Interventional, Cardiology Neovasc, Tiara, Neovasc Reducer, angina pectoris, refractory angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Phase 3 iLLUMINATE trial met primary endpoint of progression-free survival (PFS) in patients with previously untreated CLL and Small Lymphocytic Lymphoma (SLL) compared to chlorambucil plus obinutuzumab as assessed by an Independent Review Committee (IRC) ... Biopharmaceuticals, Oncology AbbVie, IMBRUVICA, ibrutinib, GAZYVA, obinutuzumab, Chronic Lymphocytic Leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
AMSTERDAM, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- BioGX B.V. continues its *BD MAX™ menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX™ Sample-to-Answer platform.... Diagnostics, Product Launch BioGX, BD , meningitis, vancomycin resistance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
Teleflex will acquire the Company's commercial coronary products and an option to purchase the drug coated Chocolate Heart(TM) SINGAPORE, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- QT Vascular Ltd., ("QT Vascular", and with its... Devices, Interventional, Cardiology, Acquisitions QT Vascular, Chocolate XD, Glider , Chocolate Heart, balloon catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

PiCSO therapy reduces infarct size in STEMI patients
Miracor Medical announces new publication at EuroPCR AWANS, Belgium, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Miracor Medical SA announced today the clinical results from the physician-sponsored OxAMI-PiCSO study were published in the ... Devices, Interventional, Cardiology Miracor Medical, OxAMI-PiCSO study, PiCSO Impulse System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Dr. David Tuck, CMO, to retire and return to academia LEXINGTON, Mass., May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and eff... Biopharmaceuticals, Oncology, Personnel Curis , fimepinostat (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO
SAN DIEGO, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Calidi Biotherapeutics, Inc., formerly StemImmune, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announ... Biopharmaceuticals, Oncology, Personnel Calidi Biotherapeutics, StemImmune, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
XIENCE Sierra™, the newest generation of XIENCE drug-eluting stents, received U.S. Food and Drug Administration (FDA) approval XIENCE stents are among the most-widely used and studied stents in the world and have an unparalleled safety record New fea... Devices, Interventional, Cardiology, FDA Abbott, XIENCE Sierra, drug eluting stent, coronary stent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters
SAN DIEGO, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- Access Scientific, LLC announced completion of an in vivo study demonstrating the superior anti-thrombotic (i.e., anti-clotting) property of its unique intravascular catheter material, C... Devices Access Scientific, ChronoFlex, BioGUARD, POWERWAND, catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
The agreement to bring a biosimilar of bevacizumab to the United States will improve patient access and affordability of this important oncology treatment MADRID, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- mAbxience, a company specialize... Biopharmaceuticals, Generics, Licensing mAbxience, Insud Pharma Group, Amneal Pharmaceuticals, bevacizumab, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Promising results for Tendyne valve presented as late-breaking clinical trial at EuroPCR Early data showed high rates of successful implantation and reduction of mitral regurgitation symptoms in patients in global study Device will be further studied... Devices, Interventional, Cardiology Abbott, Tendyne, Transcatheter, Mitral Valve Replacement, mitral regurgitation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
PALO ALTO, Calif., May 23, 2018 -- (Healthcare Sales & Marketing Network) -- ReCor Medical announced today that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and demonstrated a statistically significant reduction in blood pressure in hypert... Devices, Cardiology ReCor Medical, Paradise System, hypertension, Renal Denervation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
Chicago, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- AbelsonTaylor, the world's largest independent medical advertising agency, has hired Amanda Hartzmark as director of business development and analysis. Responsible for leading the agency's ... Personnel AbelsonTaylor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

SomaGenics Launches Its RealSeq(R)-biofluids Kit and Advances Liquid Biopsy Development With New NIH Funding for cf-miRNA NGS Technology
SANTA CRUZ, Calif., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- SomaGenics announced the launch of RealSeq®-biofluids, a next-generation sequencing (NGS) library construction kit sensitive enough to detect small RNAs from cell-free biofl... Diagnostics, Oncology, Product Launch SomaGenics, RealSeq, biofluids, Liquid Biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
PALO ALTO, Calif., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now r... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Sirtex Medical, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

New GLOBAL UNITE Reverse Fracture Shoulder Implant from DePuy Synthes Addresses Unmet Needs in Complex Shoulder Fractures
New system designed to preserve joint function and stability and promote bone healing WARSAW, Ind., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the... Devices, Orthopaedic, Product Launch DePuy Synthes, Johnson & Johnson, GLOBAL UNITE, Reverse Fracture Shoulder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow(TM) Ventricular System for Treatment of Hydrocephalus
Novel product provides qualified clinicians with the option of non-invasive retrograde flushing of the ventricular catheter, to unblock occluded inlet holes or open a relief membrane to restore or increase cerebrospinal fluid (CSF) flow in a non-flowing sh... Devices, Neurosurgery Anuncia , Alivio ReFlow, Ventricular System, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Late-breaking data presented at EuroPCR and simultaneously published in "The New England Journal of Medicine" support use of Abbott's PressureWire™ guidewire to help physicians make stenting decisions Stenting guided by Abbott's PressureWire d... Devices, Interventional Cardiology Abbott, PressureWire, FAME 2 study, stent, FFR, PCI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

MaxQ-AI Receives CE Mark Approval for Accipio(TM)Ix Intracranial Hemorrhage Artificial Intelligence Software Platform
TEL AVIV, Israel, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- MaxQ Artificial Intelligence (MaxQ-AI), a global artificial intelligence (AI) healthcare company, today announced that it has received the CE Mark approval for its revolutionary A... Devices, Radiology, Neurology, Regulatory MaxQ-AI, Accipio, intracranial hemorrhage, CT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance
MAASTRICHT, Netherlands, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- A highly innovative software, developed by Pie Medical Imaging - PMI - B.V. (Esaote Group) will be presented at EuroPCR 2018, the world-leading course in interventional car... Devices, Interventional Cardiology Pie Medical Imaging, CAAS vFFR, Cardiovascular Angiographic Analysis Systems (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Nobles Medical Technologies II Showcases Noblestitch(TM) PFO Closure At EuroPCR
NOBLES MEDICAL TECHNOLOGIES II, INC. (NMT2) ANNOUNCES THE PRESENTATION OF ITS ITALIAN CLINICAL DATA PUBLISHED IN EUROINTERVENTION TO BE PRESENTED BY DR. FREDERICO DEMARCO PARIS, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- NMT2 announces ... Devices, Interventional Cardiology Nobles Medical Technology II, NobleStitch EL, PFO closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared
VANCOUVER, British Columbia, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S. market ... Devices, Neurology, Product Launch WAT Medical Enterprise, EmeTerm, neuromodulation, nausea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow IRVINE, Calif., May 21, 2018 -- (Healthcare Sales & Marketing Network) -- CERENOVUS, part of the Johnson & Johnson Medical Devices Compa... Devices, Interventional, Radiology, Neurology, FDA CERENOVUS, Johnson & Johnson, EMBOTRAP, Revascularization, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
New Survey Shows Nearly Two out of Three Women Believe Their Hands Make Them Look Older than Their Age1† FORT WORTH, Texas, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- Nestlé Skin Health, a global leader focused on meeting the worl... Devices, Dermatology, FDA Nestlé Skin Health, Restylane Lyft, Restylane, dermal filler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
SAN CARLOS, Calif., May 18, 2018 -- (Healthcare Sales & Marketing Network) -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the appointment of Frances Rena Bahjat, Ph.D. as Vice President, Discovery Research. In this newly-cr... Biopharmaceuticals, Oncology, Personnel Apexigen, APXiMAB (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Migraine is a Severe Neurologic Disease That Profoundly Impacts Millions of Patients in the United States Aimovig is the First and Only FDA-Approved Treatment to Block the Calcitonin Gene-Related Peptide Receptor (CGRP-R), Which Plays an Important Role ... Biopharmaceuticals, Devices, Drug Delivery, FDA Amgen, Aimovig, erenumab, migraine, SureClick, autoinjector (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2018 Category: Pharmaceuticals Source Type: news

Award-Winning Olympus Brings a "Full Circle" Urology Offering to AUA
EMPOWER Laser Portfolio Is Unveiled and Featured in Hands-On Session; New Line Features Full Range of Lithotripsy Modes Including Dusting, Stone Stabilization and Soft Tissue CENTER VALLEY, Pa., May 17, 2018 -- (Healthcare Sales & Marketing Network) --... Devices, Urology, Product Launch Olympus, Olympus Medical Systems, EMPOWER laser, Ho:YAG, lithotripsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
SILVER SPRING, Md., May 17, 2018 -- (Healthcare Sales & Marketing Network) -- No patients should be priced out of medicines they need to support their health. As stressed by the President and Secretary Azar last week, one of the Administration's highest pr... Biopharmaceuticals, Generics, FDA U.S. Food and Drug Administration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Olympus Expands Its Endoscope Reprocessing Portfolio to Include ChanlDry Drying Cabinet, Endo SafeStack Transport Cart and Visual Reprocessing Guide
Expansion Underscores Olympus' Endoscope Protection and Infection Prevention for Device's Full Journey through Facility CENTER VALLEY, Pa., May 17, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and d... Devices, Product Launch Olympus, Olympus Medical Systems, ChanlDry, Drying Cabinet, endoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news